Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹325.90down ₹3.15 (0.96%)BSE ₹326.15
Share price at the NSE close on 29 Oct 2026. Previous close ₹329.05.
29 Oct: open ₹329.00, high ₹331.70, low ₹323.05
52-week range of traded prices to 29 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,996 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.39
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,41247.9% delivered
Panacea Biotec dividends
9 filed, newest first.
May 2019
May 2018
May 2016
May 2011
13 May · Dividend
Board of Directors at its meeting held on May 13, 2011 has recommended dividend of Re.0.75 (75%) each on Equity Shares of the Company, for the financial year 2010-11. The total amount of dividend payable, if approved by Shareholders in their ensuing Annual General Meeting, shall be Rs.45.9 million, excluding dividend distribution tax.
May 2010
7 May · Dividend
Board of Directors at its meeting held on May 07, 2010 has recommended dividend of Re.0.25 (25%) each on Equity Shares of the Company, for the financial year 2009-10. The total amount of dividend payable, if approved by Shareholders, shall be Rs.16.7 million, excluding dividend distribution tax.
Sep 2008
5 Sep · Dividend
Panacea Biotec Ltd. has informed the Exchange that the dividend, if declared at the forthcoming Annual General Meeting, will be paid on or before October 26, 2008.
Jun 2008
26 Jun · Dividend
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on June 26, 2008 has recommended dividend @ 100% (i.e. Re. 1/- per Share) on Equity Shares of the Company, for the financial year 2007-08.
Sep 2007
6 Sep · Dividend
Panacea Biotec Ltd. had informed the Exchange that the Board had recommended dividend at the rate of 100% (i.e. Re. 1 per Equity share of Re. 1 each) on the Equity Share Capital of the Company in their meeting held on July 24,2007. The company has now informed the Exchange that the said dividend, if declared at the forthcoming Annual General Meeting, will be paid on or before October 28,2007. Further, the dividend on the Equity Shares, if approved, will absorb an amount of Rs.65,855,192/-.
Jun 2007
14 Jun · Dividend
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company held on June 14, 2007 has recommended dividend @ 100% (i.e. Re.1/- per Share) on Equity Shares of the Company, for the financial year 2006-07.